The efficiency and safety of tenoten for anxiety and depression disorders in epileptics has been demonstrated. The drug does not change the incidence and severity of epileptic episodes, does not deteriorate the course of the underlying disease, and can be well combined with anticonvulsants. The results indicate the effi ciency of tenoten used to arrest the anxio-depressive disorders in epilepsy.
Similar content being viewed by others
References
G. N. Avakyan, Atmosfera, No. 4, 4-8 (2005).
O. I. Epstein, M. B. Stark, A. M. Dygai, et al., Pharmacology of Ultralow Dose Antibodies to Endogenous Function Regulators [in Russian], Moscow (2005).
B. Baran, M. Farkas, and P. Rajna, Ideggyogy Sz., 55, No. 9-10, 303-310 (2002).
M. J. Jackson and D. Turkington, J. Neurol. Neurosurg. Psychiatry, 76, Suppl. 1, i45-i47 (2005).
T. Kapitany, G. Glauninger, and B. Schimka, Psychiatrische Aspekte, Wien (2001).
W. A. Kues and F. Wunder, Eur. J. Neurosci., 4, No. 12, 1296-1308 (1992).
P. Kwan and M. J. Brodie, Lancet, 357, 216-222 (2001).
A. Scicutella and A. B. Ettinger, Epilepsy Behav., 3, No. 55, 10-12 (2002).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 153, No. 5, pp. 660-663, May, 2012
Rights and permissions
About this article
Cite this article
Delger, A.B., Avakyan, G.N., Oleinikova, O.M. et al. Effects of Tenoten on Anxiety and Depression Disorders in Patients with Epilepsy. Bull Exp Biol Med 153, 704–706 (2012). https://doi.org/10.1007/s10517-012-1804-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-012-1804-7